scholarly journals Rediscovered and Unforgotten: Transcatheter Interventions for the Treatment of Severe Tricuspid Valve Regurgitation

2021 ◽  
Vol 15 ◽  
Author(s):  
Kusha Rahgozar ◽  
Sharon Bruoha ◽  
Edwin Ho ◽  
Ythan Goldberg ◽  
Mei Chau ◽  
...  
Keyword(s):  
Tricuspid Valve ◽  
Valve Regurgitation ◽  
Poor Survival ◽  
Tricuspid Valve Regurgitation ◽  
The Past ◽  
Time Period ◽  
Long Term Follow Up ◽  
Transcatheter Interventions

Tricuspid valve regurgitation is both globally prevalent and undertreated. Historically, surgical intervention for isolated tricuspid regurgitation (TR) was avoided despite the prevalence of TR, largely due to poor surgical outcomes and an incomplete understanding of how it independently affects mortality. Over the past two decades, TR has been shown by several studies to be an independent predictor of worse functional status and poor survival on long-term follow-up. During this same time period, transcatheter interventions for the treatment of valvular heart disease have evolved dramatically. While the transcatheter repair and replacement of the tricuspid valve in patients with severe TR remains in the early stages of investigation relative to the mitral or aortic valve, the field is rapidly expanding. Here, the authors review the field of transcatheter tricuspid valve interventions for severe TR, focusing on the orthotropic devices and valves currently available worldwide.

scholarly journals Uni-port total thoracoscopic surgery versus median sternotomy for redo tricuspid valve replacement: A retrospective study

2020 ◽  
Author(s):  
Licheng Yan ◽  
Fuzhen Zheng ◽  
Haiyu Chen ◽  
Jiayin Bao ◽  
Guoxing Weng
Keyword(s):  
Valve Replacement ◽  
Tricuspid Valve ◽  
Thoracoscopic Surgery ◽  
Median Sternotomy ◽  
Control Group ◽  
Study Group ◽  
Valve Regurgitation ◽  
Tricuspid Valve Replacement ◽  
Tricuspid Valve Regurgitation

Abstract BACKGROUNDː This study compared the perioperative and follow-up period data of patients who underwent redo tricuspid valve replacements performed via thoracoscopic surgery or median sternotomy. The purpose was to evaluate the feasibility, safety, and surgical outcomes of redo tricuspid valve replacement via uni-port thoracoscopic surgery. METHODSː Forty-nine patients with severe tricuspid valve regurgitation after left-side valve replacement underwent redo tricuspid valve replacements in our hospital from April 2012 to September 2019. 26 patients underwent uni-port total thoracoscopy surgery, whereas 23 patients had the surgery performed via median sternotomy. We collected perioperative and 3- to 36-month postoperative data. RESULTSː No deaths occurred in the intraoperative period. Time of cardiopulmonary bypass in the study group was significantly longer than that in the control group (P<0.05), but the operative times in the study and control groups were not significantly different. Thoracic drainage, length of ICU stay, postoperative hospital stay and complication rates in the study group were significantly different from those in the control group (P<0.05). Throughout the follow-up period, uni-port total thoracoscopic TVR is not inferior to traditional surgery with respect to cardiac function and recurrence of tricuspid valve regurgitation. CONCLUSIONSː Uni-port total thoracoscopic tricuspid valve replacement is safe, feasible and effective, and that can be considered as a primary treatment strategy for patients with severe TR after previous left-sided valve procedure.

A flash from the past: a case on long term follow-up of a “corridor” operation

2013 ◽  
Vol 46 (1) ◽  
pp. 54-56
Author(s):  
Danilo Ricciardi ◽  
Andrea Sarkozy ◽  
Kristel Wauters ◽  
Pedro Brugada
Keyword(s):  
The Past ◽  
Long Term Follow Up

A Novel Transcatheter Edge-to-Edge Suturing Technique and Prototype for Repairing Tricuspid Valve Regurgitation

2020 ◽  
Author(s):  
Jorge D. Zhingre Sanchez ◽  
Paul A. Iaizzo
Keyword(s):  
Tricuspid Valve ◽  
Valve Regurgitation ◽  
Surgical Equipment ◽  
Tricuspid Valve Regurgitation ◽  
Clinical Issue ◽  
Risk Of Mortality ◽  
Repair Procedure ◽  
Equipment Testing ◽  
Transcatheter Interventions ◽  
Leaflet Coaptation

Abstract Tricuspid valve regurgitation is a major clinical issue that continues to attract interest from interventional cardiologists and medical device designers due to its rising prevalence and progressive nature. This disease impact is exacerbated among the aging population, considered as high risk of mortality for open-heart surgical procedures. Furthermore, early intervention for tricuspid regurgitation following left-sided heart procedures continues to increase. Thus, percutaneous or transcatheter interventions have emerged as the new frontier for tricuspid valve therapy. Specifically, tricuspid leaflet plication, or edge-to-edge repair, is a valvular procedure to enhance the coaptation of the leaflets and reduce regurgitation. The current landscape of approved transcatheter devices for leaflet coaptation are exclusive to the mitral valve or being investigated for tricuspid treatment. However, most of these transcatheter systems are designed with high procedure specificities, are expensive, and require extensive procedural training. Hence, there is an opportunity to percutaneously plicate the tricuspid leaflets using commonly available right-heart catheter equipment. This study details a novel transcatheter repair procedure that can plicate the tricuspid valve leaflets solely using current market released catheters and/or surgical equipment. Testing and evaluation of this prototype procedure was performed using Visible Heart® methodologies.

scholarly journals Tricuspid Valve Regurgitation Immediately After Heart Transplant and Long-Term Outcomes

2019 ◽  
Vol 107 (5) ◽  
pp. 1348-1355 ◽  
Author(s):  
Muath Bishawi ◽  
Giorgio Zanotti ◽  
Linda Shaw ◽  
Michael MacKenzie ◽  
Anthony Castleberry ◽  
...  
Keyword(s):  
Tricuspid Valve ◽  
Heart Transplant ◽  
Valve Regurgitation ◽  
Long Term Outcomes ◽  
Tricuspid Valve Regurgitation

Long-term effect of atrial fibrillation on the evolution of mitral and tricuspid valve regurgitation

2019 ◽  
Vol 75 (7) ◽  
pp. 639-647
Author(s):  
L. Pype ◽  
L. Embrechts ◽  
B. Cornez ◽  
C. Van Paesschen ◽  
A. Sarkozy ◽  
...  
Keyword(s):  
Atrial Fibrillation ◽  
Tricuspid Valve ◽  
Term Effect ◽  
Valve Regurgitation ◽  
Tricuspid Valve Regurgitation ◽  
Long Term Effect

The Switch Back Ross Operation: Report of Two Cases With Good Medium-to-Long-Term Follow-Up

2012 ◽  
Vol 3 (2) ◽  
pp. 244-248 ◽  
Author(s):  
Walter Vicente ◽  
Cesar Augusto Ferreira ◽  
Jyrson Guilherme Klamt ◽  
Paulo Henrique Manso ◽  
Oswaldo Cesar Almeida Filho ◽  
...  
Keyword(s):  
Arterial Switch Operation ◽  
Valve Surgery ◽  
Valve Regurgitation ◽  
Ross Operation ◽  
Switch Operation ◽  
Long Term Follow Up ◽  
Good Medium ◽  
The Ideal

Submitted July 20, 2011; Accepted October 6, 2011. Neoaortic root dilatation and neoaortic valve regurgitation following the arterial switch operation for transposition of the great arteries may ultimately require neoaortic root and/or neoaortic valve surgery. The ideal surgical approach to these lesions remains debatable. Hazekamp et al, in 1997, introduced the replacement of the neoaortic root by the neopulmonary autograft and named this procedure the switch back Ross operation. We report two patients who were successfully treated at our institution with the switch back Ross operation, with good results at, respectively, four- and five-year follow-up.

scholarly journals Long-term results (up to 14 years) of the clover technique for the treatment of complex tricuspid valve regurgitation†

2017 ◽  
Vol 52 (1) ◽  
pp. 125-130 ◽  
Author(s):  
Michele De Bonis ◽  
Elisabetta Lapenna ◽  
Stefania Di Sanzo ◽  
Benedetto Del Forno ◽  
Federico Pappalardo ◽  
...  
Keyword(s):  
Tricuspid Valve ◽  
Long Term Results ◽  
Valve Regurgitation ◽  
Tricuspid Valve Regurgitation
Sign in / Sign up

Export Citation Format

Share Document